On second thought, it's Proteomics!
Or, once you're a few years older -- Aging Intervention Therapeutics!
BioForesight comprises the most active, knowledgeable and visible team of business development and corporate partnering experts in the areas of therapeutic antibodies, proteomics, pharmaco-proteomics, genomics and chemo-genomics, as applied to therapeutic product development in oncology, infectious disease, CNS disorders, and the molecular basis of aging. We are the originators and co-chairs of such first-in-class conferences as Strategic Research Institute's (SRI's) 'Trends in Antibody Dealmaking & Financing'; and SRI's "Anti-Aging Drug Discovery & Development Summit: Exploring the Molecular Basis of Aging & Commercial Prospects for Therapeutic Interventions".
ABOUT BIOSCIENCE VENTURES, INC.:
David Palella is the President of BioScience Ventures Inc., a San Diego-based consulting firm founded in 1991 specializing in global strategic alliances in the biopharmaceutical, diagnostics and biotech/biomedical fields. David has extensive business expertise in the fields of therapeutic antibodies, proteomics, genomics and therapeutic strategies for aging intervention.
BioScience Ventures has raised over US$ 70 million for U.S. and European clients since 1995, including several funded research collaborations in the range of US$ 10-15 million.
Past and current clients of BioScience Ventures include Biosite Inc.; Karo Bio AB/Novalon Pharmaceutical Corp.; NeuroGenix/MGi Applied Genomics; EPIcyte Pharmaceutical; Tragen/Immunogenex; Genetastix; Display Systems Biotech A/S; Structural Bioinformatics; CyberChemics; MediLite Diagnostika; Charybdis Technologies; CombiChem Inc.; Eisai Co.; COGNIS; Empyrean Diagnostics; GeriGene Medical Corp.; Hisamitsu Pharmaceutical Co.; Kaken Pharmaceutical Co.; Mitsubishi Chemical Corp.; Molecular Research Institute; Nippon Kayaku Co.; SangStat Medical Corp.; Sumitomo Chemical Co.; Argonex; and Teijin Ltd.
David received an MBA, BS and BA from Arizona State University and an MS from Chaminade University in Honolulu, Hawaii.
Contact information:
David Palella
President
BIOSCIENCE VENTURES, INC.
3830 Valley Centre Drive
Suite 705 / PMB #581
San Diego, CA 92130-3307
tel: 858-793-0741
fax: 858-793-0742
email: dpalella@san.rr.com
web site: http://www.bioforesight.com
